Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reverse transcriptase inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 38, Issue 6, 1994, Pages 1404-1407

  Byrnes, V W ^a   Emini, E A ^a   Schleif, W A ^a   Condra, J H ^a   Schneider, C L ^a   Long, W J ^a   Wolfgang, J A ^a   Graham, D J ^a   Gotlib, L ^a   Schlabach, A J ^a   Wolanski, B S ^a   Blahy, O M ^a   Quintero, J C ^a   Rhodes, A ^a   Roth, E ^a   Titus, D L ^a   Sardana, V V ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(4,7 DICHLORO 2 BENZOXAZOLYLMETHYL)AMINO] 5 ETHYL 6 METHYL 2(1H) PYRIDONE; 9 CHLORO 4,5,6,7 TETRAHYDRO 5 METHYL 6 (3 METHYL 2 BUTENYL)IMIDAZO[4,5,1 JK][1,4]BENZODIAZEPINE 2(1H) THIONE; DIDANOSINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ENZYME INHIBITION; ENZYME PURIFICATION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NOTE; PRIORITY JOURNAL; VIRUS INACTIVATION; VIRUS MUTANT; VIRUS MUTATION; VIRUS RESISTANCE;

EID: 0028333887     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.38.6.1404     Document Type: Note

References (0)